Wayne Berson
Report of the Chair of the Audit
and Finance Committee
GAVI Alliance Board meeting
Dar es Salaam, Tanzania, 4 -5 December 2012
GAVI Alliance Board meeting
4-5 December 2012
Activity since June 2012 Board meeting
? 3 Video/teleconference meetings reviewing

? Areas reviewed;
? Audit & Financial Reporting
? Financial Forecasts / Commitments
? Other Matters



1

Barry Greene
Financial Forecast
GAVI Alliance Board meeting
Dar es Salaam, Tanzania, 4 -5 December 2012
GAVI Alliance Board meeting
4-5 December 2012
Projected demand
1



2011 -15 :
$7.8 bn

2016 -20:
$8.3 bn
Indicative

Needs are prior to:
? Any new
options
? Monitoring IRC
adjustments `
-
500
1,000
1,500
2,000
2,500
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
GAVI Cash Outflows Estimates (US$ millions)
2011 -2020
Vaccines Programmes Cash Based Programmes Business Plan
2012 -15: $1.7 bn per year 2016 -20: $1.6 bn per year

Helen Evans
Barry Greene
GAVI Alliance Business Plan
2013 -14


GAVI Alliance Board meeting
Dar es Salaam, Tanzania, 4 -5 December 2012


GAVI Alliance Board Meeting
4-5 December 2012
Business Plan 2013 ? 1 4 process
June
Board
Define high level priorities
for 2013 ?14
Dec
Board
Adjust business plan
and budget
1 2
? Definition of deliverables,
activities and budgets
? Peer review through
implementing partners
? Review by:
? EC (September)
? PPC (October)
? AFC/ PPC (November)
? EC (November)
? Board (December)
? Review the experience over
the first 2 years
? Interviews with many Board
members
? Workshops with Board
constituencies for
? SG 1, 2 & 3
? M & E
Validate
strategic priorities
TODAY:
Approve
Business Plan
1

Marie -Ange Saraka -Yao
David Ferreira
Long term funding strategy
GAVI Alliance Board meeting
Dar es Salaam, Tanzania, 4 -5 December 2012
GAVI Alliance Board meeting
4-5 December 2012
Building on the Alliance?s success

2000 -11 2011 -15 2016 -20
1
Contribute to
averting
4 million future
deaths
Contribute to
averting approx.
5 million future
deaths

Contribute to
averting
over 5.5 million
future deaths
Driven by the introduction
of pentavalent vaccines
Driven by scaled up
pentavalent vaccine
launches, and introduction
of pneumococcal and
rotavirus vaccines
Driven by scaled up rollouts
of the current vaccine and
HSS portfolio, as well as
introducing potential other
vaccines (subject to the VIS)

United Republic of Tanzania
Dr. Hussein Ali Mwinyi (MP)
Minister of Health
GAVI Alliance Board Meeting
5 December 2012
Hyatt Regency Hotel, Dar es Salaam,
Tanzania

Background
Area = 940,000 sq km
Population. = est. 45m (2012)
Average growth rate = 2%
MMR = 454/100,000
TANZANIA
Life expectancy = 58yrs
Under five Mortality =81/1000

Helen Evans
Risk management update
GAVI Alliance Board meeting
Dar e s Salaam, Tanzania, 4 ? 5 December 2012
GAVI Alliance Board meeting
4-5 December 2012
Risk identification and mitigation: four key
components
? Quarterly risk register :
? Assess, track and mitigate global risks for GAVI
? Reviewed by internal auditor

? Transparency and Accountability policy :
? Assess, track and mitigate risk of use of cash by countries

? Country grant agreement :
? Clarifies expectations and responsibilities vis -? -vis use of GAVI
grants (vaccines and cash)

? Reporting to the Board



1

Aur?lia Nguyen
Paul Kelly
GAVI and fragile states: a
country by country approach
GAVI Alliance Board meeting
Dar es Salaam, Tanzania, 4 -5 December 2012
GAVI Alliance Board meeting
4-5 December 2012
Background
? Board December 2011: requested the Secretariat ?to develop a
policy that clearly defines the GAVI Alliance?s approach to fragile
and under -performing countries?.

? PPC April 2012 :
? F ragility and immunisation performance not statistically linked
? R ecommended the development of a framework

? PPC October 2012 :
? Recommended the country by country approach to the Board



1

David Ferreira and Paul Kelly

New strategy for polio eradication:
possible GAVI & IFFIm participation
GAVI Alliance Board meeting
Dar es Salaam, Tanzania, 4 -5 December 2012
GAVI Alliance Board meeting
4-5 December 2012
Significant momentum around polio eradication
1
? Timing: Record low number of
cases in smallest geographic area
? Polio already under consideration
? GAVI Board in April 2012 discussed IPV
as part of routine immunisation
? Shift to prioritise routine
immunisation
? Essential part of draft Polio Endgame
Strategic Plan 2013 -18
? SAGE last month recommended switch
from trivalent OPV to bivalent OPV with
a dose of IPV
Source: GPEI website

Hind Khatib -Othman
Country Programme and Health
System Support Update
GAVI Alliance Board meeting
Dar es Salaam, Tanzania, 4 -5 December 2012
COUNTRY PROGRAMMES
1
Country Support
Vaccine
Implementation
Technical
Support

Barry Greene
Health Campus option for
Geneva office space
GAVI Alliance Board meeting
Dar es Salaam, Tanzania, 4 -5 December 2012
GAVI Alliance Board meeting
4-5 December 2012
Geneva office space ? currently
? Current lease runs through 2016, renewable
for 5 years 2017 -2021
? GAVI is the sole tenant
? Space is adequate for our needs
? Rent: $2.5m per year
1

IFFIm R eport



Ren? Karsenti
Chair , IFFIm Board




GAVI Board Meeting
Dar es Salaam, Tanzania
5 December 2012


International Finance Facility for Immunisation
IFFIm Board?s goals
? N avigate IFFIm credit rating challenges
? Operate as non -triple A issuer
? Enhance IFFIm?s funding sources
? Advocate for and promote IFFIm at capital markets conferences
? Promote investor awareness in socially responsible investments
such as vaccine bonds
? Expand and diversify IFFIm donor base
? Seek support from new and existing donors as part of GAVI?s next
replenishment effort


GAVI Alliance Board meeting
4-5 December 2012
2

Review of decisions GAVI Alliance Board meeting
Dar es Salaam, Tanzania, 4-5 December 2012
GAVI Alliance Board meeting4-5 December 2012
Decision 1: Board/ Committee member
appointments (1/14)
1
The GAVI Alliance Board:
(a)
Appointed the following Board members:
�
Orin Levine as Board Member representing the Bill & Melinda Gat es
Foundation in the seat currently held by Christophe r J. Elias effective
1 January 2013 until his successor is appointed and qualified.
�
Zulfiqar A. Bhuttaas Board Member representing research and
technical health institutes in the seat currently h eld by Anne Schuchat
effective 1 January 2013 until 31 December 2015.
�
Awa Marie Coll-Seck of Senegal as Board Member representing
developing country governments in the seat formerly held by
Toupta Boguena (Chad) effective immediately until 31 December 2015.